A change in the epidemiology of infections due to extended-spectrum β-lactamase-producing organisms

被引：0
|
作者：
Rodriguez-Baño, J
Paterson, DL
机构：
[1] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA 15213 USA
[2] Hosp Univ Virgen Macarena, Secc Enfermedades Infecciosas, Seville, Spain
来源：
CLINICAL INFECTIOUS DISEASES | 2006年 / 42卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：935 / 937
页数：3
相关论文
共 50 条
  • [41] Molecular epidemiology of a citywide outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection
    Quale, JM
    Landman, D
    Bradford, PA
    Visalli, M
    Ravishankar, J
    Flores, C
    Mayorga, D
    Vangala, K
    Adedeji, A
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 834 - 841
  • [42] Epidemiology of Extended-Spectrum β-Lactamase-Producing Escherichia coli in the Human-Livestock Environment
    Nüesch-Inderbinen M.
    Stephan R.
    Current Clinical Microbiology Reports, 2016, 3 (1) : 1 - 9
  • [43] Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011
    Brolund, A.
    Edquist, P. J.
    Makitalo, B.
    Olsson-Liljequist, B.
    Soderblom, T.
    Wisell, K. Tegmark
    Giske, C. G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (06) : O344 - O352
  • [44] Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
    Lautenbach, E
    Strom, BL
    Bilker, WB
    Patel, JB
    Edelstein, PH
    Fishman, NO
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1288 - 1294
  • [45] Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections
    Qureshi, Zubair A.
    Paterson, David L.
    Pakstis, Diana L.
    Adams-Haduch, Jennifer M.
    Sandkovsky, Gabriel
    Sordillo, Emilia
    Polsky, Bruce
    Peleg, Anton Y.
    Bhussar, Manveen K.
    Doi, Yohei
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (01) : 26 - 32
  • [46] Extended-Spectrum β-Lactamase-Producing Bacterial Infections in Adult Solid Organ Transplant Recipients
    Winters, Holli A.
    Parbhoo, Rupal K.
    Schafer, Jason J.
    Goff, Debra A.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (03) : 309 - 316
  • [47] Noncarbapenems for the Treatment of Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Bacteria
    White, C. Whitney
    Kyle, Jeffrey A.
    Deas, Crystal M.
    Campbell, Jacob
    SOUTHERN MEDICAL JOURNAL, 2019, 112 (08) : 438 - 443
  • [48] Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms?
    Sharara, Sima L.
    Amoah, Joe
    Pana, Zoi D.
    Simner, Patricia J.
    Cosgrove, Sara E.
    Tamma, Pranita D.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : E331 - E337
  • [49] Ertapenem for the treatment of extended-spectrum β-lactamase-producing gram-negative bacterial infections
    Teng, C. P.
    Chen, H. H.
    Chan, J.
    Lye, D. C. B.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (04) : 356 - 359
  • [50] Evaluation of Antibiotics for the Treatment of Bacteremia Due to Extended-spectrum β-Lactamase-producing Escherichia coli
    Sugawara, Takafumi
    Murakami, Noritaka
    Uetake, Nobue
    Hiraki, Kouichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (06): : 829 - 833
12345